Skip to main content
. 2016 Jun 20;9:3661–3669. doi: 10.2147/OTT.S96427

Table 2.

B7.1 expression in AML and MDS subgroups

Group N B7.1 expression (%)
AML 121 62 (51.24%)
 M1 14 3 (21.43%)
 M2 45 29 (64.44%)a
 M4 24 5 (20.83%)
 M5 38 25 (65.79%)b
MDS 88 9 (10.23%)
 RAEB 60 5 (8.33%)
 RAEBT 28 4 (14.28%)

Notes:

a

P<0.05 vs other AML subtype.

b

P<0.05 vs MDS subtype.

Abbreviations: AML, acute myeloid leukemia; MDS, myelodysplastic syndrome; RAEB, refractory anemia with excess blasts; RAEBT, refractory anemia with excess blasts in transformation.